WuXi AppTec (OTCMKTS:WUXAY) Sets New 52-Week High – Should You Buy?

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY)’s share price reached a new 52-week high during trading on Wednesday . The company traded as high as $19.72 and last traded at $19.72, with a volume of 1218 shares. The stock had previously closed at $19.60.

Analysts Set New Price Targets

Separately, Zacks Research raised shares of WuXi AppTec to a “hold” rating in a research report on Monday, April 13th. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy”.

WuXi AppTec Stock Up 0.6%

The company has a fifty day moving average price of $16.67 and a 200-day moving average price of $15.24.

WuXi AppTec (OTCMKTS:WUXAY) last announced its quarterly earnings results on Monday, April 27th. The company reported $0.23 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.05. The company had revenue of $1.82 billion for the quarter, compared to analysts’ expectations of $1.59 billion.

About WuXi AppTec

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.